Behavioral analysis of male and female Fmr1 knockout mice on C57BL/6 background

Behavioural Brain Research

Volumn 271, Issue , 2014, Pages 72-78

  Ding, Qi ^a   Sethna, Ferzin ^a   Wang, Hongbing ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Behavioral phenotypes; Fmr1 knockout mice; Fragile X syndrome; Gender; Genetic background

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; AUDIOGENIC SEIZURE; COGNITIVE DEFECT; CONTEXTUAL FEAR MEMORY; CONTROLLED STUDY; EXPLORATORY BEHAVIOR TEST; FEMALE; FRAGILE X SYNDROME; GENDER; HIPPOCAMPUS; HYPERACTIVITY; JUVENILE ANIMAL; KNOCKOUT MOUSE; LIGHT DARK TEST; LOCOMOTION; MALE; MEMORY; MOUSE; NONHUMAN; OPEN FIELD TEST; PASSIVE AVOIDANCE; PREPULSE INHIBITION; PRIORITY JOURNAL; STARTLE REFLEX; ANIMAL; ANIMAL BEHAVIOR; AVOIDANCE BEHAVIOR; C57BL MOUSE; DISEASE MODEL; FEAR; GENETICS; HYPERKINESIA; MOTOR ACTIVITY; PHENOTYPE; PSYCHOLOGY; SEX DIFFERENCE;

FRAGILE X MENTAL RETARDATION PROTEIN;

ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; FEAR; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HYPERKINESIS; MALE; MEMORY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; PHENOTYPE; REFLEX, STARTLE; SEX FACTORS;

EID: 84902682356     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.05.046     Document Type: Article

References (41)

1. Bagni C., Tassone F., Neri G., Hagerman R. Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics. J Clin Invest 2012, 122:4314-4322.
2. Pieretti M., Zhang F.P., Fu Y.H., Warren S.T., Oostra B.A., Caskey C.T., et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 1991, 66:817-822.
3. Verkerk A.J., Pieretti M., Sutcliffe J.S., Fu Y.H., Kuhl D.P., Pizzuti A., et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991, 65:905-914.
4. Brown V., Jin P., Ceman S., Darnell J.C., O'Donnell W.T., Tenenbaum S.A., et al. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 2001, 107:477-487.
5. Darnell J.C., Van Driesche S.J., Zhang C., Hung K.Y., Mele A., Fraser C.E., et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 2011, 146:247-261.
6. Ascano M., Mukherjee N., Bandaru P., Miller J.B., Nusbaum J.D., Corcoran D.L., et al. FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature 2012, 492:382-386.
7. Jin P., Zarnescu D.C., Ceman S., Nakamoto M., Mowrey J., Jongens T.A., et al. Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat Neurosci 2004, 7:113-117.
8. Edbauer D., Neilson J.R., Foster K.A., Wang C.F., Seeburg D.P., Batterton M.N., et al. Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron 2010, 65:373-384.
9. Santoro M.R., Bray S.M., Warren S.T. Molecular mechanisms of fragile X syndrome: a twenty-year perspective. Annu Rev Pathol 2012, 7:219-245.
10. Westmark C.J., Malter J.S. FMRP mediates mGluR5-dependent translation of amyloid precursor protein. PLoS Biol 2007, 5:e52.
11. Lu R., Wang H., Liang Z., Ku L., O'Donnell W.T., Li W., et al. The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. Proc Nat Acad Sci USA 2004, 101:15201-15206.
12. Gross C., Nakamoto M., Yao X., Chan C.B., Yim S.Y., Ye K., et al. Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome. J Neurosci 2010, 30:10624-10638.
13. Huber K.M., Gallagher S.M., Warren S.T., Bear M.F. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Nat Acad Sci USA 2002, 99:7746-7750.
14. Osterweil E.K., Krueger D.D., Reinhold K., Bear M.F. Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome. J Neurosci 2010, 30:15616-15627.
15. Sharma A., Hoeffer C.A., Takayasu Y., Miyawaki T., McBride S.M., Klann E., et al. Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci 2010, 30:694-702.
16. Bhattacharya A., Kaphzan H., Alvarez-Dieppa A.C., Murphy J.P., Pierre P., Klann E. Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice. Neuron 2012, 76:325-337.
17. Sethna F., Moon C., Wang H. From FMRP function to potential therapies for fragile X syndrome. Neurochem Res 2014, [Epub ahead of print].
18. Wang H., Ferguson G.D., Pineda V.V., Cundiff P.E., Storm D.R. Overexpression of type-1 adenylyl cyclase in mouse forebrain enhances recognition memory and LTP. Nat Neurosci 2004, 7:635-642.
19. Zhang M., Moon C., Chan G.C., Yang L., Zheng F., Conti A.C., et al. Ca-stimulated type 8 adenylyl cyclase is required for rapid acquisition of novel spatial information and for working/episodic-like memory. J Neurosci 2008, 28:4736-4744.
20. Yan Q.J., Asafo-Adjei P.K., Arnold H.M., Brown R.E., Bauchwitz R.P. A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse. Genes Brain Behav 2004, 3:337-359.
21. Veeraragavan S., Bui N., Perkins J.R., Yuva-Paylor L.A., Carpenter R.L., Paylor R. Modulation of behavioral phenotypes by a muscarinic M1 antagonist in a mouse model of fragile X syndrome. Psychopharmacology (Berl) 2011, 217:143-151.
22. Goebel-Goody S.M., Wilson-Wallis E.D., Royston S., Tagliatela S.M., Naegele J.R., Lombroso P.J. Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model. Genes Brain Behav 2012, 11:586-600.
23. Pietropaolo S., Guilleminot A., Martin B., D'Amato F.R., Crusio W.E. Genetic-background modulation of core and variable autistic-like symptoms in Fmr1 knock-out mice. PLoS One 2011, 6:e17073.
24. Baker K.B., Wray S.P., Ritter R., Mason S., Lanthorn T.H., Savelieva K.V. Male and female Fmr1 knockout mice on C57 albino background exhibit spatial learning and memory impairments. Genes Brain Behav 2010, 9:562-574.
25. Qin M., Kang J., Smith C.B. A null mutation for Fmr1 in female mice: effects on regional cerebral metabolic rate for glucose and relationship to behavior. Neuroscience 2005, 135:999-1009.
26. Yan Q.J., Rammal M., Tranfaglia M., Bauchwitz R.P. Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology 2005, 49:1053-1066.
27. Qin M., Kang J., Smith C.B. Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation. Proc Nat Acad Sci USA 2002, 99:15758-15763.
28. Liu Z.H., Chuang D.M., Smith C.B. Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome. Int J Neuropsychopharmacol 2011, 14:618-630.
29. Yuskaitis C.J., Mines M.A., King M.K., Sweatt J.D., Miller C.A., Jope R.S. Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome. Biochem Pharmacol 2010, 79:632-646.
30. Mineur Y.S., Sluyter F., de Wit S., Oostra B.A., Crusio W.E. Behavioral and neuroanatomical characterization of the Fmr1 knockout mouse. Hippocampus 2002, 12:39-46.
31. Veeraragavan S., Bui N., Perkins J.R., Yuva-Paylor L.A., Paylor R. The modulation of fragile X behaviors by the muscarinic M4 antagonist, tropicamide. Behav Neurosci 2011, 125:783-790.
32. Spencer C.M., Alekseyenko O., Serysheva E., Yuva-Paylor L.A., Paylor R. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome. Genes Brain Behav 2005, 4:420-430.
33. Veeraragavan S., Graham D., Bui N., Yuva-Paylor L.A., Wess J., Paylor R. Genetic reduction of muscarinic M4 receptor modulates analgesic response and acoustic startle response in a mouse model of fragile X syndrome (FXS). Behav Brain Res 2012, 228:1-8.
34. Qin M., Xia Z., Huang T., Smith C.B. Effects of chronic immobilization stress on anxiety-like behavior and basolateral amygdala morphology in Fmr1 knockout mice. Neuroscience 2011, 194:282-290.
35. Paradee W., Melikian H.E., Rasmussen D.L., Kenneson A., Conn P.J., Warren S.T. Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function. Neuroscience 1999, 94:185-192.
36. Dobkin C., Rabe A., Dumas R., El Idrissi A., Haubenstock H., Brown W.T. Fmr1 knockout mouse has a distinctive strain-specific learning impairment. Neuroscience 2000, 100:423-429.
37. Thomas A.M., Bui N., Graham D., Perkins J.R., Yuva-Paylor L.A., Paylor R. Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome. Behav Brain Res 2011, 223:310-321.
38. Spencer C.M., Alekseyenko O., Hamilton S.M., Thomas A.M., Serysheva E., Yuva-Paylor L.A., et al. Modifying behavioral phenotypes in Fmr1KO mice: genetic background differences reveal autistic-like responses. Autism Res 2011, 4:40-56.
39. Lauterborn J.C., Rex C.S., Kramar E., Chen L.Y., Pandyarajan V., Lynch G., et al. Brain-derived neurotrophic factor rescues synaptic plasticity in a mouse model of fragile X syndrome. J Neurosci 2007, 27:10685-10694.
40. Nielsen D.M., Derber W.J., McClellan D.A., Crnic L.S. Alterations in the auditory startle response in Fmr1 targeted mutant mouse models of fragile X syndrome. Brain Res 2002, 927:8-17.
41. Frankland P.W., Wang Y., Rosner B., Shimizu T., Balleine B.W., Dykens E.M., et al. Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice. Mol Psychiatry 2004, 9:417-425.